Kadimastem is a regenerative medicine company focused on the industrial development and commercialization of stem cell-based therapeutics, primarily for diabetes and neurodegenerative disorders. The company’s proprietary technologies and know-how enable the differentiation of stem cells into insulin secreting beta cells as well as a range of neural cells, including Oligodendrocytes and Astrocytes. Based on its differentiation technologies, the company advances two therapeutic programs focused on diabetes mellitus and ALS, where stem cells are differentiated into beta cells for the diabetes program and astrocytes are differentiated into beta cells for the ALS program, with the goal of implanting them into patients, and affecting diseases progression. The company’s technology is designed to screen compounds automatically and quantify the readouts using a cell-based High Content Screening (HCS) system. Kadimastem partners with pharmaceutical companies to screen potential drug compounds on its stem-cell derived cells. It produces a number of human cell and tissue systems that constitute screening platforms to search for agonists or antagonists of specific biological processes, with the aim of developing safe drugs. Kadimastem is based in Nes Ziona, Israel.

Yihui Technology (Shenzhen) Co., Ltd., established on 2017-12-12, Business scope includes general business items:Class I medical device,R&D and sales of smart devices;Electromechanical equipment and accessories,electronic product,computer,Sales and technical development of computer software and hardware,technical consulting;Health and wellness management consulting(Does not contain medical behavior);Business Management Consulting;Domestic Trade;Operating import and export business.(above laws,Administrative regulations,Except for items that are subject to approval prior to registration by decision of the State Council,Restricted projects must obtain a license before operating),The licensing program is:Class II medical device,R&D and sales of biomedicine;Medical Technology Consulting.

Institute of Laboratory Animal Science, a subsidiary of University of Zurich, is a Swiss company located in Schlieren that provides research, services and teaching in translational and basic research.

University Health Network (UHN) is a healthcare and medical research organization in Toronto, Ontario, Canada. It is the largest such research organization in Canada and North America, ranking first in Canada for total research funding. It was named Canada's top research hospital by Research Infosource in 2015, 2016 and 2017. It was created in 1986 by the Government of Ontario through the merger of four major hospitals: Toronto General Hospital, Toronto Western Hospital, with the Princess Margaret Cancer Centre, and the Toronto Rehabilitation Institute merged in with The Toronto Hospital in 1999 and the name changed to the University Health Network. All four hospitals are affiliated with the Faculty of Medicine at the University of Toronto and serve as teaching hospitals for resident physicians, nurses, and other healthcare professions. UHN also operates The Michener Institute, an applied health sciences college that opened in 1958.

Organ Technologies was founded to spark a new industrial revolution starting from Japan which is one of the health care’s hottest growth fields: regenerative medicine. Our mission is to promote the health and welfare of people all over the world through our novel bio-engineering technologies designed to produce realistic organs that are functionally equivalent to natural ones.

Chongqing Justeng Biotechnology Co., Ltd., established on 2021-03-19, Business scope includes general items:R&D and application of cell technology;Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;software development;Specialty Chemicals Sales(Free of Hazardous Chemicals);Information Technology Consulting Services;Health Consulting Services(Does not include medical services);Remote Health Management Services;Business Management Consulting;marketing planning;Information Consulting Service(Not including licensing information consulting services);Consulting and planning service;internet sales(Except for products that require a license for sale);market survey(Does not include foreign investigations).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Riken Corp. engages in the manufacture and sale of engine and vehicular components. It operates through the Automotive and Machinery Parts, and Others segments. The Automotive and Machinery Parts segment deals with the company's core products such as piston rings, camshafts, seal rings for transmissions, high-grade cast iron products, and valve lifters. The Others segment includes plumbing equipment business, Electromagnetic Compatibility (EMC) business, and thermal engineering business, The company was founded by Masatoshi Okochi in November 1927 and is headquartered in Tokyo, Japan.

Jianyi Biotechnology Development (Shandong) Co., Ltd., established on 2022-03-30, Business scope includes general items:R&D and application of cell technology;Medical Research and Experimental Development;Health Consulting Services(Does not include medical services);Traditional Chinese Medicine Health Care Services(non-medical);Research and development of bio-based materials technology;Technology intermediary service;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;software development;Biochemical product technology research and development;Conference and Exhibition Services;business training(Does not include education and training,Vocational skills training and other licensed training);advertising;Advertising Design,acting;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Healthy food(prepackaged)Sales.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:medical service;Class III medical device business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Zhejiang Hongrui Medical Technology Co., Ltd., established on 2021-01-05, Business scope includes general items:Medical Research and Experimental Development;Sales of Class II Medical Devices;Production of Class I Medical Devices;Sales of Class I Medical Devices;Chemical product production(No licensed chemical products);Manufacturing of plastic products;electronic(gas)Manufacturing of physical equipment and other electronic equipment;Communication equipment manufacturing;Research and development of bio-based materials technology;Manufacturing of bio-based materials;New material technology research and development;New material technology promotion service;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Research and development of bio-based material polymerization technology;Biochemical product technology research and development;Specialty Chemicals Sales(Free of Hazardous Chemicals);Health Consulting Services(Does not include medical services);marketing planning;Professional cleaning,to clean,Disinfection service;Conference and Exhibition Services;Chemical product sales(No licensed chemical products);Information Consulting Service(Not including licensing information consulting services);Socioeconomic Advisory Services;Business Management Consulting;Engineering and Technology Research and Experimental Development;Big data service;Information system integration service;market survey(Does not include foreign investigations);hospital management;software development;Nursing facility services(Does not include medical services);Calculator Equipment Sales;electronics sales;Artificial intelligence application software development;Artificial intelligence public data platform;Health Supplies(non food)Production;Health Supplies(non food)Sales(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Class III medical device business;Production of Class II Medical Devices;Production of Class III Medical Devices;Production of medical masks;Production of hygiene products and single-use medical products;pharmaceutical production;Drug retail;Drug Wholesale;medical service;Health food production;Health food sales(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Shanghai Suojing Biotechnology Co., Ltd., established on 2018-08-14, The scope of business includes engaging in biotechnology,Medical Technology,Technology development in the professional field of instrumentation technology,technology transfer,technical consulting,Technical Services,laboratory equipment,Green facilities,medical instruments(Only varieties that do not require a medical device license),computer,Software and Auxiliary Equipment,electronic product,Rubber products,Chemical raw materials and products,chemical reagent(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals),Instrument sales. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Accurate International is engaged in the research and development of regenerative medicines based on the four centers of organoid tissue and disease models. clinical medicine transformation, big data sharing, and smart device development.

StemoniX, Inc. provides IPS-based platforms for pharmacy and research institutions. It offers microBrain 3D Assay Ready, microBrain 2D Assay Ready, microPlate, microHeart Assay Ready, and microHeart Cell Ready. The company was founded by Yung-Ping Yeh and Robert Petcavich in 2014 and is headquartered in Maple Grove, MN.

Jiangsu Xinanjia Medical Technology Co., Ltd., established on 2018-06-27, Business scope includes medical technology development,Technical Services,Technology Transfer and Technology Consulting;software development;Equipment,Class I medical device,Chemical Products(Does not contain dangerous goods),Labor protection supplies,Sales of Office Supplies;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

West China Second University Hospital is a Chinese private company located in Chengdu. The firm provides women and children healthcare services.